Summary of Significant Accounting Policies (Details) - Schedule of finite-lived and indefinite-lived intangible assets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 15,518,000
Accumulated Amortization and Impairment	(7,869,468)	$ (7,437,206)
Effect of Foreign Exchange Rates	(250,199)	(639,820)
Net Balance	7,398,333	7,440,974
Trademarks and tradenames [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	1,768,000
Accumulated Amortization and Impairment	(521,674)	(469,011)
Effect of Foreign Exchange Rates	(29,101)	(62,520)
Net Balance	1,217,225	1,236,469
Distributor relationships [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	2,362,000
Accumulated Amortization and Impairment	(464,633)	(417,728)
Effect of Foreign Exchange Rates	(38,879)	(83,525)
Net Balance	1,858,488	1,860,747
A50 – Developed technology [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	349,000
Accumulated Amortization and Impairment	(147,126)	(132,273)
Effect of Foreign Exchange Rates	(5,744)	(12,342)
Net Balance	196,130	204,385
Ares – Developed technology [Member] | Ares Genetics [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,333,000
Accumulated Amortization and Impairment	(1,123,957)	(1,010,495)
Effect of Foreign Exchange Rates	(82,553)	(183,132)
Net Balance	4,126,490	4,139,373
A30 – In-Process Research & Development [Member] | Curetis N.V [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	5,706,000
Accumulated Amortization and Impairment	(5,612,078)	(5,407,699)
Effect of Foreign Exchange Rates	$ (93,922)	$ (298,301)